| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68083-447-25 | 68083-447 | HUMAN PRESCRIPTION DRUG | Verapamil hydrochloride | Verapamil hydrochloride | INJECTION | INTRAVENOUS | 20201015 | N/A | ANDA | ANDA214361 | Gland Pharma Limited | VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL | 25 VIAL in 1 CARTON (68083-447-25) / 2 mL in 1 VIAL |
| 68083-448-05 | 68083-448 | HUMAN PRESCRIPTION DRUG | Verapamil hydrochloride | Verapamil hydrochloride | INJECTION | INTRAVENOUS | 20201015 | N/A | ANDA | ANDA214361 | Gland Pharma Limited | VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL | 5 VIAL in 1 CARTON (68083-448-05) / 4 mL in 1 VIAL |
| 25021-312-02 | 25021-312 | HUMAN PRESCRIPTION DRUG | Verapamil Hydrochloride | Verapamil Hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20210315 | N/A | ANDA | ANDA214361 | Sagent Pharmaceuticals | VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL | 25 VIAL in 1 CARTON (25021-312-02) / 2 mL in 1 VIAL |
| 25021-312-04 | 25021-312 | HUMAN PRESCRIPTION DRUG | Verapamil Hydrochloride | Verapamil Hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20210315 | N/A | ANDA | ANDA214361 | Sagent Pharmaceuticals | VERAPAMIL HYDROCHLORIDE | 2.5 mg/mL | 5 VIAL in 1 CARTON (25021-312-04) / 4 mL in 1 VIAL |